Skip to main content
Premium Trial:

Request an Annual Quote

Allying with Syngene, Strand Genomics Eyes Cheminformatics Market

NEW YORK, June 3 (GenomeWeb Daily News) - Indian bioinformatics company Strand Genomics has entered the cheminformatics market through a newly disclosed partnership with Syngene in the field of synthetic chemistry and molecular biology, according to local media reports.

The newspaper Express Pharma Plus reported online that Vijay Chandru, chairman and CEO of Strand Genomics, said that Strand has started developing predictive models by "leveraging" its Avadis platform.

 

GenomeWeb News could not independantly verify the alliance by deadline.

 

Terms of the alliance call for Syngene to synthesize target-focused libraries developed by Strand, the paper said. The libraries would be "differentiated by the use of predictive models of drug-like properties of small molecules at the design stage," the paper reports.

Chandru is quoted as saying that the Avadis platform, when used in cheminformatics applications, "will be three to five times more remunerative than if it were used in research biology."


He told the paper that
Strandis "in talks with a number of players in the synthetic chemistry segment for potential partnership," according to the article, including Procitius Research of Sanmar group, GVK, and Sai Life Sciences.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.